Ameriprise Financial Inc Bridge Bio Pharma, Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 450,381 shares of BBIO stock, worth $12.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

450,381

Previous 34,775 1195.13%

Holding current value

$12.7 Million

Previous $880,000 1202.95%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$23.91 - $31.3 $9.94 Million - $13 Million	415,606 Added 1195.13%	450,381 $11.5 Million
Q2 2024 Aug 14, 2024	BUY	$23.0 - $31.04 $1,035 - $1,396	45 Added 0.13%	34,775 $880,000
Q1 2024 May 15, 2024	SELL	$27.35 - $40.45 $2,188 - $3,236	-80 Reduced 0.23%	34,730 $1.07 Million
Q4 2023 Feb 14, 2024	BUY	$24.02 - $43.89 $7,206 - $13,167	300 Added 0.87%	34,810 $1.41 Million
Q3 2023 Nov 14, 2023	SELL	$16.89 - $35.01 $27,784 - $57,591	-1,645 Reduced 4.55%	34,510 $910,000
Q2 2023 Aug 14, 2023	SELL	$13.29 - $18.01 $19,469 - $26,384	-1,465 Reduced 3.89%	36,155 $621,000
Q1 2023 May 15, 2023	SELL	$7.17 - $18.55 $165,605 - $428,449	-23,097 Reduced 38.04%	37,620 $623,000
Q4 2022 Feb 14, 2023	SELL	$6.74 - $11.52 $3,572 - $6,105	-530 Reduced 0.87%	60,717 $462,000
Q3 2022 Nov 14, 2022	BUY	$7.94 - $12.36 $333,892 - $519,762	42,052 Added 219.08%	61,247 $609,000
Q2 2022 Aug 15, 2022	BUY	$5.21 - $12.14 $100,005 - $233,027	19,195 New	19,195 $174,000
Q1 2022 May 16, 2022	SELL	$7.34 - $17.16 $296,330 - $692,783	-40,372 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$11.38 - $53.41 $16,387 - $76,910	-1,440 Reduced 3.44%	40,372 $674,000
Q3 2021 Nov 15, 2021	BUY	$46.87 - $64.24 $154,342 - $211,542	3,293 Added 8.55%	41,812 $1.96 Million
Q2 2021 Aug 16, 2021	BUY	$46.47 - $63.93 $153,722 - $211,480	3,308 Added 9.39%	38,519 $2.35 Million
Q1 2021 May 17, 2021	SELL	$55.47 - $72.35 $409,978 - $534,738	-7,391 Reduced 17.35%	35,211 $2.17 Million
Q4 2020 Feb 12, 2021	SELL	$38.38 - $71.11 $62,828 - $116,407	-1,637 Reduced 3.7%	42,602 $3.03 Million
Q3 2020 Nov 16, 2020	SELL	$27.2 - $42.19 $69,713 - $108,132	-2,563 Reduced 5.48%	44,239 $1.66 Million
Q2 2020 Aug 14, 2020	SELL	$22.22 - $35.69 $259,751 - $417,216	-11,690 Reduced 19.99%	46,802 $1.53 Million
Q1 2020 May 15, 2020	BUY	$16.11 - $36.23 $475,551 - $1.07 Million	29,519 Added 101.88%	58,492 $1.7 Million
Q4 2019 Feb 14, 2020	BUY	$17.96 - $46.63 $25,664 - $66,634	1,429 Added 5.19%	28,973 $1.02 Million
Q3 2019 Nov 14, 2019	BUY	$20.13 - $32.38 $48,895 - $78,651	2,429 Added 9.67%	27,544 $591,000
Q2 2019 Aug 14, 2019	BUY	$26.97 - $27.55 $677,351 - $691,918	25,115 New	25,115 $677,000

Others Institutions Holding BBIO

# of Institutions

290

Shares Held

170M

Call Options Held

10.4M

Put Options Held

2.37M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.17B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Bridge Bio Pharma, Inc. Transaction History